SOS
VRTX icon

Silver Oak Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Silver Oak Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-381
Closed -$170K – 828
2025
Q2 		$170K Buy
+381
New +$176K 0.01% 655
2024
Q4 		– Sell
-1,219
Closed -$553K – 661
2024
Q3 		$553K Buy
1,219
+20
+2% +$9.61K 0.06% 318
2024
Q2 		$562K Buy
1,199
+283
+31% +$123K 0.08% 203
2024
Q1 		$383K Sell
916
-1,433
-61% -$606K 0.06% 260
2023
Q4 		$956K Buy
2,349
+1,355
+136% +$501K 0.13% 170
2023
Q3 		$346K Sell
994
-950
-49% -$332K 0.08% 206
2023
Q2 		$684K Buy
+1,944
New +$655K 0.11% 191
2022
Q4 		– Sell
-994
Closed -$346K – 489
2022
Q3 		$346K Buy
+994
New +$286K 0.08% 206

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return